Macromomycin B

Macromomycin B

Macromomycin B is a macrolide antibiotic that is derived from the Streptomyces genus of Actinobacteria. It is a member of the macromomycin family of antibiotics, which are known for their potent antibacterial and antifungal properties.

History

Macromomycin B was first isolated in the 1970s from a strain of Streptomyces macromomyceticus. The discovery of this antibiotic marked a significant advancement in the field of pharmacology, as it provided a new tool for combating resistant strains of bacteria and fungi.

Structure and Properties

Macromomycin B is a large, complex molecule with a molecular weight of approximately 800 daltons. It is composed of a 16-membered macrolide ring, which is decorated with various sugar residues and amino acids. This complex structure is responsible for the antibiotic's potent biological activity.

Mechanism of Action

The exact mechanism of action of macromomycin B is not fully understood. However, it is believed to inhibit protein synthesis in bacteria and fungi by binding to the ribosome, thereby preventing the formation of new proteins. This inhibitory action is thought to be responsible for the antibiotic's potent antibacterial and antifungal properties.

Clinical Use

Due to its potent antibacterial and antifungal properties, macromomycin B has been used in the treatment of various infections caused by resistant strains of bacteria and fungi. However, its use is limited by its high toxicity and the development of resistance.

See Also

• Macrolide
• Antibiotic
• Streptomyces
• Actinobacteria
• Pharmacology

This article is a stub. You can help WikiMD by registering to expand it. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health & wellness encyclopedia.